格隆汇12月15日丨中伟股份(300919.SZ)公布，根据《上海证券交易所沪港通业务实施办法》和《深圳 证券交易所深港通业务实施办法》的有关规定，中伟新材料股份有限公司于香港联合交易所有限公司发 行并上市的股票（简称"H股"）自2025年12月15日起调入沪港通及深港通（统称"港股通"）标的证券名 单。本次公司H股调入港股通标的证券名单后，符合条件的中国内地投资者将可通过上海证券交易所和 深圳证券交易所直接投资公司在香港联合交易所有限公司上市的H股，有利于进一步扩大公司的投资者 基础，并将潜在提高公司H股的交易流动性。 ...

Group 1 - The company announced the approval of several key proposals during the 11th meeting of the third board of directors, including expected related party transactions for the year 2026 [1] - The company plans to apply for financing and comprehensive bank credit for the year 2026 [1] - A proposal to convene the second extraordinary general meeting of shareholders for the year 2025 was also approved [1]

Core Viewpoint - The company plans to increase its investment in its wholly-owned subsidiary, Suzhou Jinqiu, to transform it into a specialized, integrated, and intelligent water treatment business platform [1][2] Group 1: Investment Details - The company will invest 70 million yuan of its own funds into Suzhou Jinqiu, increasing its registered capital from 30 million yuan to 100 million yuan [1] - After the capital increase, the company will still hold 100% equity in Suzhou Jinqiu, which remains a wholly-owned subsidiary [1] Group 2: Strategic Goals - The core objective of the capital increase is to develop Suzhou Jinqiu into a one-stop comprehensive solution provider for water treatment, focusing on "chemical agents + membrane products + engineering + operation and maintenance + intelligent management" [1] - The company aims to establish a differentiated competitive advantage through "membrane-agent symbiosis, water efficiency reconstruction, and intelligent operation and maintenance" [1] Group 3: Financial Implications - The capital increase is based on the operational needs of Suzhou Jinqiu and is expected to provide a solid foundation for the company's production and future business development [2] - The company's financial status is stable and good, and the use of self-owned funds for this capital increase will not adversely affect normal production activities or cash flow [2]

善水科技公告，公司于2025年12月12日召开第三届董事会第二十一次会议，审议通过了《关于调整部分 募投项目计划进度的议案》，同意将募集资金投资项目达到预定可使用状态日期延长至2026年12月31 日。此次调整不改变募集资金用途，未改变募集资金的投向及项目实施方式，不会对公司正常经营产生 重大不利影响。 ...

Group 1 - The core viewpoint of the news is that Shenzhen Guanghua Weiye Co., Ltd. has initiated the IPO counseling record with the Shenzhen Securities Regulatory Bureau, aiming to list on the Beijing Stock Exchange, with Shenwan Hongyuan Securities as the counseling institution [1] - Guanghua Weiye was established on May 29, 2002, with a registered capital of 57.6 million yuan, and is involved in the production, operation, and service provision of 3D printing materials and environmentally friendly biological materials [2] - The company’s major products and services include 3D printing products and environmentally friendly biological materials [2] Group 2 - In the first half of 2025, the company achieved operating revenue of 344 million yuan, an increase of 41.43% compared to the same period last year, and a net profit of 25.45 million yuan, up 46.88% year-on-year [2] - In 2024, the company reported operating revenue of 544 million yuan, a year-on-year increase of 29.85%, while net profit was 24.18 million yuan, a decrease of 45.16% compared to the previous year [2] - The controlling shareholder of Guanghua Weiye is Yida Biological New Technology (Shenzhen) Limited Partnership, holding a direct stake of 33.05%, while Yang Yixu holds 19.91% directly and controls a total of 52.96% of the shares, making him the actual controller of the company [4]

Group 1 - The company, Binhu Chemical Co., Ltd. (stock code: 601678.SH), plans to apply for the registration and issuance of non-financial corporate debt financing instruments not exceeding RMB 1 billion to meet its operational development needs [1] - The purpose of this issuance is to further broaden financing channels, reduce financing costs, and optimize the debt structure of the company [1]

智通财经APP讯，三友化工(600409.SH)发布公告，为进一步拓宽融资渠道，优化融资结构，满足公司 经营发展需要，公司拟向中国银行间市场交易商协会申请注册发行总额度不超过人民币13亿元(含本数) 的中期票据。 ...

Group 1 - The core viewpoint of the article is that the investment in the PEEK and supporting fluoroketone projects by the company opens up long-term growth potential, maintaining a "buy" rating [1] - The company plans to invest 193 million yuan to construct an annual production capacity of 2,000 tons of the specialty polymer material PEEK and key intermediates such as 4,4′-difluorobenzophenone [1] - Previously, the company had a fluorobenzene production capacity of 650 tons per year and possessed pilot test technology for fluoroketones [1] Group 2 - The PEEK project is supported by technical collaboration with well-known domestic institutions such as Dalian University of Technology [1] - Through the investment in the PEEK project, the company is expected to establish a complete industrial chain from fluorobenzene to fluoroketones to PEEK, thereby unlocking future growth opportunities [1]

Core Viewpoint - The sulfuric acid market has experienced a significant price increase of 63.9% over two months, driven by multiple factors including costs, supply constraints, and market sentiment, with a continued upward trend expected in the short term [1][3]. Supply Side - In November, domestic sulfuric acid production capacity affected by maintenance was approximately 21.38 million tons, with concentrated repairs in key regions such as Central and East China, leading to a noticeable reduction in regional supply [3]. - The domestic sulfur market has continued to rise in December, with sulfur prices increasing significantly, driven by a 130% rise since the beginning of the year. The global sulfur supply has been disrupted due to the Russia-Ukraine conflict and reduced exports from Kazakhstan, resulting in a supply gap [3]. - Domestic port inventory of sulfur has decreased to 2.2 million tons, below reasonable levels, which has pressured sulfuric acid prices to rise [3]. Cost Side - The high prices of sulfur, a core raw material for sulfuric acid production (approximately 0.33 tons of sulfur is needed to produce 1 ton of sulfuric acid), have forced price increases due to cost pressures [3]. - The price of iron sulfide ore has also remained high, further supporting the cost structure for sulfuric acid production [5]. Demand Side - Coastal factories have abundant export orders, leading to some sulfuric acid resources being directed to international markets, which further squeezes domestic supply [5]. - The main downstream applications for sulfuric acid include phosphate fertilizers, titanium dioxide, and caprolactam, with caprolactam operating rates close to 80%, while phosphate diammonium has a lower operating rate of 50% [5]. Market Outlook - The sulfuric acid market is expected to maintain a trend of localized price increases, although resistance from downstream sectors may lead to a slowdown in future price hikes [5]. - Long-term attention should be given to the recovery of international sulfur supply and the release of production capacity after maintenance of sulfuric acid plants [5].

丙烯期货周报 大宗商品研究所 温健翔 从业资格证号： F03118724 投资咨询资格证号： Z0022792 第二章 核心逻辑分析和数据追踪 GALAXY FUTURES 1 综合分析与交易策略 【综合分析】 目录 第一章 综合分析与交易策略 本周丙烯负荷继续上升，本周丙烯开工负荷在79.31%，环比上升1.51%，丙烷及混烷脱氢周度开工在74.46%，环比上升 4.25%。丙烯工厂库存高位，巨正源共计120万吨、滨华新材料60万吨PDH装置12月重启， 恒通化工、青海盐湖共计34 万吨MTO装置近期重启。国内丙烯负荷整体预计高位，丙烯进 口减少，下游整体需求弹性仍显弱。下游产品价格走势整 体偏弱，工厂入市采购积极性降 低，市场整体交投气氛趋弱。高库存压制下，价格向上驱动不强。 【交易策略】 GALAXY FUTURES 3 丙烯基差走强 单边：丙烯价格受制于库存高企，目前供应端国内丙烯负荷仍然高位，上方空间有限，逢高做空。 套利：观望。 期权：卖看涨期权。 GALAXY FUTURES 2 目录 第一章 综合分析与交易策略 第一章 综合分析与交易策略 第二章 核心逻辑分析和数据追踪 第二章 核心逻辑分析和 ...